WORLD CLASS LEADERSHIP
Arrogene is led by a highly trained and distinguished team of experts who have demonstrated success in the combined fields of research, medicine, biologics, neuroscience, and nanotechnology along with the specialized business development track record requisite for the launch of cutting-edge medical technologies.
Management
Larry A. Couture, PhD
Chief Executive Officer
Dr. Couture’s recognized expertise–established over nearly three decades of work with experimental biologics, heavily focused on cell and gene therapies–includes organizational management, regulatory affairs, business development, process development, GMP manufacturing and clinical development.
Julia Ljubimova, MD, PhD
Founder, Chief Scientific Officer
Dr. Ljubimova directs the Nanomedicine Research Center in the Cedars-Sinai Department of Neurosurgery. She is also professor of Neurosurgery and Biomedical Sciences. Her main research interests are differential cancer gene expression as a tool for finding novel and early markers of cancer growth and development, and the design of new nanomedicine drugs against tumor targets.
Eggehard Holler, PhD
Founder, Sr. VP Product Development & Biochemistry
Dr. Holler serves as Professor of Neurosurgery at Cedars-Sinai Medical Center and Professor of Biochemistry at the University of Regensburg, Germany. Dr. Holler’s internationally renowned research focuses on design, synthesis and characterization of novel nanoscale drug delivery systems based on polymalic acid.
Alexander Ljubimova, PhD
Founder, Sr. VP Research
Dr. Alexander Ljubimov serves as Director of the Eye Program, Regenerative Medicine Institute, and as Professor of Biomedical Sciences and Neurosurgery at Cedars-Sinai Medical Center. He is also Professor of Medicine at the University of California Los Angeles David Geffen School of Medicine.
Board of Directors
Jack Kavanaugh, MD, MBA
Chairman of the Board
Dr. Kavanaugh’s expertise has focused on the health and science technology sector, capitalizing on his background in medicine and business to lead mergers, acquisitions, turnarounds, and corporate strategic development and initiatives.
Larry A. Couture, PhD
Chief Executive Officer, Director
Dr. Couture’s recognized expertise–established over nearly three decades of work with experimental biologics, heavily focused on cell and gene therapies–includes organizational management, regulatory affairs, business development, process development, GMP manufacturing and clinical development.
Julia Ljubimova, MD, PhD
Founder, Chief Scientific Officer, Director
Dr. Ljubimova directs the Nanomedicine Research Center in the Cedars-Sinai Department of Neurosurgery. She is also professor of Neurosurgery and Biomedical Sciences. Her main research interests are differential cancer gene expression as a tool for finding novel and early markers of cancer growth and development, and the design of new nanomedicine drugs against tumor targets.
Keith Black, MD
Founder, Director
Dr. Keith Black, Chairman and Professor of the Department of Neurosurgery at Cedars-Sinai, is an internationally renowned neurosurgeon and cancer researcher. He is the founding director of the Maxine Dunitz Neurosurgical Institute and Cochran Brain Tumor Center at Cedars-Sinai.
Robert M. Snukal
Director
Mr. Robert M. Snukal–President & Chief Executive Officer at National Quality Care, Inc., and Partner at SGS Productions, Inc.,has a long history of work in healthcare and the biotech field.
James E. Hosch
Director
Mr. Hosch is currently the Executive Managing Director of Investment Banking at WestPark Capital, Inc. He is a veteran investment banker with a wide range of expertise within the financial services arena.